OJEMD  Vol.2 No.4 , November 2012
Difficulties in Recruitment for a Randomised Controlled Trial of Lifestyle Intervention for Type 2 Diabetes: Implications for Diabetes Management
Abstract: Objective: To report our experience of attempting a randomised controlled trial of an intensive lifestyle intervention for early type 2 diabetes delivered in a residential setting. Methods: We established a trial requiring 84 participants (46 standard care and 38 intervention) to detect a 1% difference in HbA1c between intervention and control groups at 12 months, allowing for attrition. Ethics approval was obtained from Monash University. Results: The study was abandoned after five months of consistent promotion due to recruitment failure (four subjects recruited). Conclusion: It appears to be difficult for patients with diabetes to commit to a live-in period of education regarding lifestyle modification as a means of treating the illness. We recommend better education of patients and their doctors about the potential health benefits of lifestyle change to manage type 2 diabetes, and further research into novel methods of delivering lifestyle advice which are both effective and sustainable.
Cite this paper: G. A. Jelinek, E. Hadgkiss, C. Hassed, B. Crimmins, P. Schattner, D. Liew, R. Kausman, W. J. Inder, S. Gutbrod and T. J. Weiland, "Difficulties in Recruitment for a Randomised Controlled Trial of Lifestyle Intervention for Type 2 Diabetes: Implications for Diabetes Management," Open Journal of Endocrine and Metabolic Diseases, Vol. 2 No. 4, 2012, pp. 53-57. doi: 10.4236/ojemd.2012.24008.

[1]   D. Dunstan, S. Colagiuri, P. Zimmet, et al., “The Rising Prevalence of Diabetes and Impaired Glucose Tolerance: The Australian Diabetes, Obesity and Lifestyle Study,” Diabetes Care, Vol. 25, No. 5, 2002, pp. 829-834. doi:10.2337/diacare.25.5.829

[2]   E. L. M. Barr, D. J. Magliano, P. Z. Zimmet, et al., “The Australian Diabetes, Obesity and Lifestyle Study. Tracking the Accelerating Epidemic: Its Causes and Outcomes,” International Diabetes Institute, Melbourne, 2006.

[3]   S. F. Wetterhall, D. R. Olson, F. DeStefano, et al., “Trends in Diabetes and Diabetic Complications, 1980-1987,” Diabetes Care, Vol. 15, No. 8, 1992, pp. 960-967. doi:10.2337/diacare.15.8.960

[4]   A. C. Powers, “Diabetes Mellitus. Harrison’s Principles of Internal Medicine,” The McGraw-Hill Companies, Inc., Ohio, 2005.

[5]   S. Colagiuri, R. Colagiuri, B. Conway, et al., “DiabCo$t Australia: Assessing the Burden of Type 2 Diabetes in Australia,” Diabetes Australia, Canberra, 2003.

[6]   D. L. Kasper, E. Braunwald, A. S. Fauci, et al., “Harrison’s Principles of Internal Medicine,” 16th Edition, The McGraw-Hill Companies, Inc., New York, 2005.

[7]   P. Zimmet, K. G. M. M. Alberti, J. Shaw, “Global and Societal Implications of the Diabetes Epidemic,” Nature, Vol. 414, No. 6865, 2001, pp. 782-787. doi:10.1038/414782a

[8]   Australian Centre for Diabetes Strategies, “National Evidence Based Guidelines for the Management of Type 2 Diabetes Mellitus. Prince of Wales Hospital,” National Health and Medical Research Council, Sydney, 2005.

[9]   J. Tuomilehto and J. Lindstrom, “The Principal Trials for Prevention of Type 2 Diabetes Have Now Confirmed That Type 2 Diabetes Can Be Prevented by Life Style Changes. Prevention of Type 2 Diabetes by Life Style,” Journees Annuelles de Diabetologie de Hotel-Dieu, 2003, pp. 77-89.

[10]   C. L. Gillies, K. R. Abrams, P. C. Lambert, et al., “Pharmacological and Lifestyle Interventions to Prevent or Delay Type 2 Diabetes in People with Impaired Glucose Tolerance: Systematic Review and Meta-Analysis,” (BMJ) British Medical Journal, Vol. 334, No. 7588, 2007, pp. 334-299. doi:10.1136/bmj.39063.689375.55

[11]   A. Yuen, Y. Sugeng, T. J. Weiland, et al., “Lifestyle and Medication Interventions for the Prevention and Delay of Type 2 Diabetes in Pre-diabetes: A Systematic Review of Randomised Controlled Trials,” Australian and New Zealand Journal of Public Health, Vol. 34, No. 2, 2010, pp. 172-178.

[12]   S. L. Norris, M. M. Engelgau and K. M. Narayan, “Effectiveness of Self-Management Training in Type 2 Diabetes: A Systematic Review of Randomized Controlled Trials,” Diabetes Care, Vol. 24, No. 3, 2001, pp. 561-587. doi:10.2337/diacare.24.3.561

[13]   P. Gaede, P. Vedel, H. H. Parving, et al., “Intensified Multifactorial Intervention in Patients with Type 2 Diabetes Mellitus and Microalbuminuria: The Steno Type 2 Randomised Study,” Lancet, Vol. 353, No. 9153, 1999, pp. 617-622. doi:10.1016/S0140-6736(98)07368-1

[14]   J. S. Cramer, R. F. Sibley, D. P. Bartlett, et al., “An Adaptation of the Diabetes Prevention Program for Use with High-Risk, Minority Patients with Type 2 Diabetes,” Diabetes Education, Vol. 33, No. 3, 2007, pp. 503-508. doi:10.1177/0145721707301680

[15]   M. J. Davies, S. Heller, T. C. Skinner, et al., “Effectiveness of the Diabetes Education and Self Management for Ongoing and Newly Diagnosed (DESMOND) Programme for People with Newly Diagnosed Type 2 Diabetes: Cluster Randomised Controlled Trial,” (BMJ) British Medical Journal, Vol. 336, No. , 2008, pp. 491-495. doi:10.1136/bmj.39474.922025.BE

[16]   T. A. Deakin, J. E. Cade, R. Williams, et al., “Structured Patient Education: The Diabetes X-PERT Programme Makes a Difference,” Diabetic Medicine, Vol. 23, No. 9, 2006, pp. 944-954. doi:10.1111/j.1464-5491.2006.01906.x

[17]   S. H. Kim, S. J. Lee, E. S. Kang, et al., “Effects of Lifestyle Modification on Metabolic Parameters and Carotid Intima-Media Thickness in Patients with Type 2 Diabetes Mellitus,” Metabolism, Vol. 55, No. 8, 2006, pp. 1053-1059. doi:10.1016/j.metabol.2006.03.017

[18]   C. K. Roberts and R. J. Barnard, “Effects of Exercise and Diet on Chronic Disease,” Journal of Applied Physiology, Vol. 98, No. 1, 2005, pp. 3-30. doi:10.1152/japplphysiol.00852.2004

[19]   M. Trento, P. Passera, M. Bajardi, et al., “Lifestyle Intervention by Group Care Prevents Deterioration of Type II Diabetes: A 4-Year Randomized Controlled Clinical Trial,” Diabetologia, Vol. 45, No. 9, 2001, pp. 1231-1239. doi:10.1007/s00125-002-0904-8

[20]   G. A. Jelinek, T. J. Weiland, G. Moore, et al., “Screening for Type 2 Diabetes with Random Finger-Prick Glucose and Bedside HbA1c in an Australian Emergency Department,” Emergency Medicine & Australasian, Vol. 22, No. 5, 2010, pp. 427-434. doi:10.1111/j.1742-6723.2010.01333.x

[21]   T. J. Weiland, M. Nguyen and G. A. Jelinek, “Illness Perception and Knowledge with Regard to Prediabetes and Type 2 Diabetes: A Pilot Study of Emergency Department Patients and Staff,” European Journal of Emergency Medicine, Vol. 19, No. 6, 2011, pp. 353-358.

[22]   Training in Flexible, Intensive Insulin Management to Enable Dietary Freedom in People with Type 1 Diabetes: Dose Adjustment for Normal Eating (DAFNE) Randomised Controlled Trial,” (BMJ) British Medical Journal, Vol. 325, 2002, p. 746. doi:10.1136/bmj.325.7367.746

[23]   Y. Ohkubo, H. Kishikawa, E. Araki, et al., “Intensive Insulin Therapy Prevents the Progression of Diabetic Microvascular Complications in Japanese Patients with Non-Insulin-Dependent Diabetes Mellitus: A Randomized Prospective 6-Year Study,” Diabetes Research and Clinical Practice, Vol. 28, No. 2, 1995, pp. 103-117. doi:10.1016/0168-8227(95)01064-K

[24]   J. P. Burke, S. M. Haffner, S. P. Gaskill, et al., “Reversion from Type 2 Diabetes to Nondiabetic Status. Influence of the 1997 American Diabetes Association Criteria,” Diabetes Care, Vol. 21, No. 8, 1998, pp. 1266-1270. doi:10.2337/diacare.21.8.1266

[25]   E. Hadgkiss, G. Jelinek, T. Weiland, et al., “Health-Related Quality of Life Outcomes at 1 and 5 Years after a Residential Retreat Promoting Lifestyle Modification for People with Multiple Sclerosis,” Neurological Sciences, in press, 2012.

[26]   M. P. Li, G. A. Jelinek, T. J. Weiland, et al., “Effect of a Residential Retreat Promoting Lifestyle Modifications on Health-Related Quality of Life in People with Multiple Sclerosis,” Quality in Primary Care, Vol. 18, No. 8, 2010, pp. 379-389.

[27]   S. Colagiuri, D. Davies, S. Girgis, et al., “National Evidence Based Guideline for Case Detection and Diagnosis of Type 2 Diabetes,” Diabetes Australia, Canberra, 2009.

[28]   W. C. Knowler, E. Barrett-Connor, S. E. Fowler, et al., “Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin,” New England Journal of Medicine, Vol. 346, No. 6, 2002, pp. 393-403. doi:10.1056/NEJMoa012512